Repeat Intrathecal Triamcinolone Acetonide Application Reduces Acute Occurring Painful Dysesthesia in Patients with Relapsing Remitting Multiple Sclerosis | Zendy

Kerstin Hellwig | Zendy; Carsten Lukas | Zendy; N. Brune | Zendy; Volker Hoffmann | Zendy; Sebastian Schimrigk | Zendy; H. Przuntek | Zendy; Thomas Müller | Zendy

Open Access

Repeat Intrathecal Triamcinolone Acetonide Application Reduces Acute Occurring Painful Dysesthesia in Patients with Relapsing Remitting Multiple Sclerosis

Author(s) -

Kerstin Hellwig,

Carsten Lukas,

N. Brune,

Volker Hoffmann,

Sebastian Schimrigk,

H. Przuntek,

Thomas Müller

Publication year - 2006

Publication title -

the scientific world journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.453

H-Index - 93

eISSN - 2356-6140

pISSN - 1537-744X

DOI - 10.1100/tsw.2006.86

Subject(s) - medicine , multiple sclerosis , triamcinolone acetonide , dysesthesia , anesthesia , intrathecal , lesion , relapsing remitting , gabapentin , spinal cord , surgery , pathology , immunology , psychiatry , alternative medicine

We describe four patients with relapsing remitting multiple sclerosis (RRMS) who experienced a relapse with acute onset of painful sensations. Pain sensations disappeared in two of them and markedly reduced in the other ones after repeat application of intrathecal triamcinolone acetonide (TCA) following a prior unsuccessful treatment with intravenous steroids. TCA administration was well tolerated and no serious side effects occurred. Repeated intrathecal TCA injection may provide a substantial benefit in RRMS patients with acute onset of pain due to an inflammatory lesion within the spinal cord.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research